Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse Hall

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 18, 2018
Metabolism and disposition of lesinurad, a uric acid reabsorption inhibitor, in humansVishal Shah, Chun Yang, Zancong Shen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 2, 2018
Metabolism and Disposition of Verinurad, a Uric Acid Reabsorption Inhibitor, in HumansCaroline A Lee, Chun Yang, Vishal Shah, et al.
Modern Rheumatology|October 19, 2018
Safety and efficacy of verinurad, a selective URAT1 inhibitor, for the treatment of patients with gout and/or asymptomatic hyperuricemia in the United States and Japan: Findings from two phase II trialsDavid Fitz-Patrick, Kent Roberson, Kiyoshi Niwa, et al.
RMD Open|April 17, 2018
Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label studyRoy Fleischmann, Peter Winkle, Jesse Hall, et al.
RMD Open|March 14, 2018
Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label studyRoy Fleischmann, Peter Winkle, Jeffrey N Miner, et al.
Journal of Clinical Pharmacology|May 8, 2018
Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Multiple Dose Administration of Verinurad (RDEA3170) and Allopurinol in Adult Male Subjects With GoutMartin Kankam, Jesse Hall, Michael Gillen, et al.
ACS Chemical Neuroscience|December 26, 2022
Evaluation of an Adoptive Cellular Therapy-Based Vaccine in a Transgenic Mouse Model of α-synucleinopathyWinston T Chu, Jesse Hall, Anjela Gurrala, et al.
Clinical Drug Investigation|June 28, 2018
Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Verinurad, a Selective Uric Acid Reabsorption InhibitorWilliam B Smith, Jesse Hall, Jolene K Berg, et al.
Frontiers in Microbiology|February 10, 2016
Temperature-Dependent Gentamicin Resistance of Francisella tularensis is Mediated by Uptake ModulationKathleen Loughman, Jesse Hall, Samantha Knowlton, et al.
Critical Care Medicine|March 17, 2006
A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patientsShannon S Carson, John P Kress, Jo Ellen Rodgers, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 18, 2018
Metabolism and disposition of lesinurad, a uric acid reabsorption inhibitor, in humansVishal Shah, Chun Yang, Zancong Shen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 2, 2018
Metabolism and Disposition of Verinurad, a Uric Acid Reabsorption Inhibitor, in HumansCaroline A Lee, Chun Yang, Vishal Shah, et al.
Modern Rheumatology|October 19, 2018
Safety and efficacy of verinurad, a selective URAT1 inhibitor, for the treatment of patients with gout and/or asymptomatic hyperuricemia in the United States and Japan: Findings from two phase II trialsDavid Fitz-Patrick, Kent Roberson, Kiyoshi Niwa, et al.
RMD Open|April 17, 2018
Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label studyRoy Fleischmann, Peter Winkle, Jesse Hall, et al.
RMD Open|March 14, 2018
Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label studyRoy Fleischmann, Peter Winkle, Jeffrey N Miner, et al.
Journal of Clinical Pharmacology|May 8, 2018
Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Multiple Dose Administration of Verinurad (RDEA3170) and Allopurinol in Adult Male Subjects With GoutMartin Kankam, Jesse Hall, Michael Gillen, et al.
ACS Chemical Neuroscience|December 26, 2022
Evaluation of an Adoptive Cellular Therapy-Based Vaccine in a Transgenic Mouse Model of α-synucleinopathyWinston T Chu, Jesse Hall, Anjela Gurrala, et al.
Clinical Drug Investigation|June 28, 2018
Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Verinurad, a Selective Uric Acid Reabsorption InhibitorWilliam B Smith, Jesse Hall, Jolene K Berg, et al.
Frontiers in Microbiology|February 10, 2016
Temperature-Dependent Gentamicin Resistance of Francisella tularensis is Mediated by Uptake ModulationKathleen Loughman, Jesse Hall, Samantha Knowlton, et al.
Critical Care Medicine|March 17, 2006
A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patientsShannon S Carson, John P Kress, Jo Ellen Rodgers, et al.
Pageof 4